Expression profiling by high throughput sequencing
Summary
We determined that CSKi treatment affects oncogenic signaling in DLBCL. We sought to measure gene expression change in DLBCL cells by RNA-sequencing following CSKi treatment.
Overall design
TMD8 and DOHH2 cells were treated in duplicates with DMSO or CSKi (500nm) for 1h, 3h, 6h and 24h.